A positive NICE evaluation sends a powerful signal to NHS commissioners, payers and international markets


NICE HealthTech guidance evaluates diagnostics, medical technologies and interventional procedures. It helps the NHS invest in impactful healthtech – and backs the developers behind them. 

It considers healthtech products that are in early development but may offer potential value to the NHS, be suitable for routine widespread use, or are already in existing use in the NHS. It includes guidance on the effectiveness and safety of interventional procedures.

Find out how it can help you. 

Want to know when NICE is evaluating healthtech in your field? Subscribe to NICE News and stay ahead of NICE’s healthtech priorities.